GAITHERSBURG, Md., May 4, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in the BofA Securities 2023 Health Care Conference.

Conference Details:

Fireside Chat


Thursday, May 11, 2023


10:00 – 10:30 a.m. Pacific Daylight Time (PDT)


Encore Hotel in Las Vegas, Nevada


Alec Stranahan, Ph.D., Equity Research Analyst – Biotechnology

Novavax participants:

John C. Jacobs, President and Chief Executive Officer and

Filip Dubovsky, M.D., President, Research & Development



Investor Meetings


Wednesday, May 10, 2023 - Thursday, May 11, 2023

A replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at for 90 days from the date of the conference.

About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined.

Please visit and LinkedIn for more information.

Erika Schultz | 240-268-2022

Ali Chartan or Giovanna Chandler | 240-709-5563

Novavax Logo (PRNewsfoto/Novavax)


Cision View original content to download multimedia:

SOURCE Novavax, Inc.

Copyright 2023 PR Newswire

Historical Stock Chart
Von Aug 2023 bis Sep 2023 Click Here for more Novavax Charts.
Historical Stock Chart
Von Sep 2022 bis Sep 2023 Click Here for more Novavax Charts.